GLAXF - GlaxoSmithKline plc (GSK) CEO Emma Walmsley Presents at CECP's Biopharma Investor Forum Conference (Transcript)

GlaxoSmithKline plc (GSK) CECP’s Biopharma Investor Forum Conference June 08, 2021 08:40 AM ET Company Participants Emma Walmsley - CEO Conference Call Participants Elaine Quilici - Senior Editor, MJH LIfe Sciences Presentation Elaine Quilici Good morning, everyone. I'm Elaine Quilici, Senior Editor of Pharmaceutical Executive Magazine. I have the pleasure of introducing our first presenter of the day, GSK's Chief Executive Officer, Dame Emma Walmsley. Emma has been CEO and Board Director since April 2017. Prior to this, she was CEO of GSK Consumer Health, a joint venture between GSK and Novartis. She's been in a member of GFK's corporate executive team since 2011 and began her career with the Company in 2010, with responsibility for consumer healthcare in Europe. Last year, Emma was appointed the honorable title of Dame for her service to the pharmaceutical industry and business, and we're honored to have her here with us today. Before

For further details see:

GlaxoSmithKline plc (GSK) CEO Emma Walmsley Presents at CECP's Biopharma Investor Forum Conference (Transcript)